No serious adverse effect due to the COVAXIN vaccine reveals interim finding from phase 1 clinical trial

Dec 16, 2020

New Delhi [India], December 16 : No serious adverse effect related to the vaccine has been reported by COVID-19 vaccine (BBV152) COVAXIN, the...

FDA removes hold on clinical trial for phase 2,3 for COVAXIN-BBV152 says Ocugen

May 23, 2022

Malvern (Pennsylvania) [US], May 23 : Biotechnology company Ocugen on Monday announced that the US Food and Drug Administration (FDA) lifted the clinical hold...

Lancet Infectious Diseases study compare well with phase 3 clinical trials of COVAXIN: Bharat Biotech

Nov 25, 2021

New Delhi [India], November 25 : Commenting on the study of the Lancet Infectious Diseases on the effectiveness of COVAXIN (BBV152) against symptomatic RT-PCR,...

Covaxin 50 pc effective against symptomatic COVID: Lancet study

Nov 24, 2021

New Delhi [India], November 24 : Two doses of COVID-19 vaccine Covaxin (BBV152) are 50 per cent effective against symptomatic COVID-19 disease, according to...

Covaxin booster dose increases immune response by 40 times, gives long-term immunity against COVID-19: Bharat Biotech

Jul 20, 2022

Hyderabad (Telangana) [India], July 20 : Hyderabad-based Bharat Biotech on Wednesday announced that the administration of the third dose of its COVID-19 vaccine Covaxin...

Kerala man, who received Covaxin vaccine, gets Covaxin in second dose

Jul 27, 2021

Wayanad (Kerala) [India], July 27 : An elderly man who received the first dose of Covaxin was allegedly administered Covishield in his second dose...